发明名称 Treatment of Obesity or Diabetes with Bile Acid Sequestrants
摘要 Provided herein are methods of treating obesity and diabetes with labile bile acid sequestrants. An effective amount of a labile bile acid sequestrant may be orally administered to an obese or diabetic individual. A labile bile acid sequestrant provided herein may have a low affinity in the colon or rectum of a human for at least one bile acid or bile acid mimic that stimulates L-cells. A labile bile acid sequestrant may be a non-systemic labile bile acid sequestrant.
申请公布号 US2011152204(A1) 申请公布日期 2011.06.23
申请号 US20100969388 申请日期 2010.12.15
申请人 SATIOGEN PHARMACEUTICALS, INC. 发明人 GEDULIN BRONISLAVA;GREENE, JR. HOWARD E.
分类号 A61K31/56;A61K31/09;A61K31/131;A61K31/132;A61K31/14;A61K31/155;A61K31/20;A61P3/04;A61P3/10 主分类号 A61K31/56
代理机构 代理人
主权项
地址